Ionis says 'unprecedented' data support Tryngolza's label expansion in severe triglyceride disease

Ionis Pharmaceuticals’ Tryngolza has succeeded in two crucial late-stage tests that could considerably broaden the drug's commercial reach, the company said Tuesday. Ionis is mulling how to price the drug in these patients, who have ...